Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. May 1994; 62(5): 1813–1819.
PMCID: PMC186414

Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.


To assess the role of capsular serotypes in the virulence of Streptococcus pneumoniae, we have constructed isogenic derivatives differing only in the type of capsule expressed. Strains of types 2, 5, and 6B were converted to type 3 by transformation and selection for an erythromycin resistance marker linked to the type 3 capsule locus. Characterization studies revealed that these type 3 derivatives were indistinguishable from the type 2, type 5, and type 6B parental strains in terms of restriction enzyme fragment pattern and expression of pneumococcal surface protein A (PspA). Expression of the type 3 capsule did not alter the mouse virulence of the similarly virulent type 2 strain. However, alteration of capsule type had a profound effect on the virulence of the type 5 and type 6B derivatives. The highly virulent type 5 strain was essentially avirulent when expressing the type 3 capsule. Conversely, the 50% lethal dose of the relatively avirulent type 6B strain was reduced > 100-fold when the type 3 capsule was expressed. Thus, the serotype of capsule expressed has a major effect on virulence, and this effect is dependent upon the genetic background of the recipient strain.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Braconier JH, Odeberg H. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae. J Lab Clin Med. 1982 Aug;100(2):279–287. [PubMed]
  • Briles DE, Claflin JL, Schroer K, Forman C. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature. 1981 Nov 5;294(5836):88–90. [PubMed]
  • Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun. 1992 Jan;60(1):111–116. [PMC free article] [PubMed]
  • Briles DE, Forman C, Crain M. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect Immun. 1992 May;60(5):1957–1962. [PMC free article] [PubMed]
  • Briles DE, Horowitz J, McDaniel LS, Benjamin WH, Jr, Claflin JL, Booker CL, Scott G, Forman C. Genetic control of the susceptibility to pneumococcal infection. Curr Top Microbiol Immunol. 1986;124:103–120. [PubMed]
  • Briles DE, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med. 1981 Mar 1;153(3):694–705. [PMC free article] [PubMed]
  • Brown EJ, Hosea SW, Hammer CH, Burch CG, Frank MM. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest. 1982 Jan;69(1):85–98. [PMC free article] [PubMed]
  • Crain MJ, Waltman WD, 2nd, Turner JS, Yother J, Talkington DF, McDaniel LS, Gray BM, Briles DE. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun. 1990 Oct;58(10):3293–3299. [PMC free article] [PubMed]
  • Fine DP. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun. 1975 Oct;12(4):772–778. [PMC free article] [PubMed]
  • Finland M, Barnes MW. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol. 1977 Feb;5(2):154–166. [PMC free article] [PubMed]
  • Giebink GS, Verhoef J, Peterson PK, Quie PG. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun. 1977 Nov;18(2):291–297. [PMC free article] [PubMed]
  • Gray BM, Dillon HC., Jr Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis. 1986 Mar-Apr;5(2):201–207. [PubMed]
  • Hostetter MK. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis. 1986 Apr;153(4):682–693. [PubMed]
  • Jansson PE, Lindberg B, Anderson M, Lindquist U, Henrichsen J. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation. Carbohydr Res. 1988 Oct 15;182(1):111–117. [PubMed]
  • Jansson PE, Lindberg B, Lindquist U. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 5. Carbohydr Res. 1985 Jul 1;140(1):101–110. [PubMed]
  • Kenne L, Lindberg B. The structure of the Streptococcus pneumoniae type 29 polysaccharide: a re-examination. Carbohydr Res. 1988 Dec 31;184:288–291. [PubMed]
  • Knecht JC, Schiffman G, Austrian R. Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide. J Exp Med. 1970 Sep 1;132(3):475–487. [PMC free article] [PubMed]
  • Matthay KK, Mentzer WC, Wara DW, Preisler HK, Lameris NB, Ammann AJ. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. Infect Immun. 1981 Jan;31(1):228–235. [PMC free article] [PubMed]
  • McDaniel LS, Sheffield JS, Swiatlo E, Yother J, Crain MJ, Briles DE. Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb Pathog. 1992 Oct;13(4):261–269. [PubMed]
  • McDaniel LS, Scott G, Kearney JF, Briles DE. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med. 1984 Aug 1;160(2):386–397. [PMC free article] [PubMed]
  • McDaniel LS, Scott G, Widenhofer K, Carroll JM, Briles DE. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies. Microb Pathog. 1986 Dec;1(6):519–531. [PubMed]
  • McDaniel LS, Sheffield JS, Delucchi P, Briles DE. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect Immun. 1991 Jan;59(1):222–228. [PMC free article] [PubMed]
  • Stephens CG, Williams RC, Jr, Reed WP. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977 Aug;17(2):296–302. [PMC free article] [PubMed]
  • Szu SC, Clarke S, Robbins JB. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun. 1983 Feb;39(2):993–999. [PMC free article] [PubMed]
  • van de Rijn I, Kessler RE. Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun. 1980 Feb;27(2):444–448. [PMC free article] [PubMed]
  • Viering TP, Fine DP. Genetic analysis of Streptococcus pneumoniae serotypes with the use of DNA fingerprinting. J Infect Dis. 1989 Jul;160(1):76–82. [PubMed]
  • Waltman WD, McDaniel LS, Gray BM, Briles DE. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microb Pathog. 1990 Jan;8(1):61–69. [PubMed]
  • Winkelstein JA, Abramovitz AS, Tomasz A. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J Immunol. 1980 May;124(5):2502–2506. [PubMed]
  • Yother J, Forman C, Gray BM, Briles DE. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun. 1982 Apr;36(1):184–188. [PMC free article] [PubMed]
  • Yother J, Handsome GL, Briles DE. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J Bacteriol. 1992 Jan;174(2):610–618. [PMC free article] [PubMed]
  • Yother J, McDaniel LS, Briles DE. Transformation of encapsulated Streptococcus pneumoniae. J Bacteriol. 1986 Dec;168(3):1463–1465. [PMC free article] [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...